Skip to main content
 

CSC’s Cancer Policy Institute supports FDA Access to User Fees

Friday, September 20, 2013

On September 10, 2013 the Cancer Support Community’s Cancer Policy Institute sent a letter of thanks and support to those Members of Congress who recently introduced legislation to protect the Food and Drug Administration’s (FDA) user fees from sequestration.

In 2012, Congress passed the FDA Safety and Innovation Act (FDASIA). As a result, new fees – paid by drug and device manufacturers – were instituted to provide the FDA with a much needed funding stream to provide for improvements to their drug and device review processes. This dedicated funding stream was designed to facilitate timely patient access to safe and effective new and generic medicines, medical devices and diagnostics.

The Lung Cancer Community Speaks Out

Wednesday, July 17, 2013

During a public meeting at the Food and Drug Administration (FDA) last month, a lung cancer survivor shared her experience. When she was diagnosed years ago, the first thing her doctor said to her was, “How should we begin your smoking cessation program?”

The woman had never even been a smoker—just like one out of every five people living with lung cancer.

She then pointed out that even if she had been, 60% of people diagnosed with lung cancer have already quit smoking, and many long-time smokers became addicted when they were just teens—and for many, that was before government warnings and stricter laws on advertising